April 2010
Volume 51, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2010
Roles of Osteopontin in Development of Choroidal Neovascularization in Mice
Author Affiliations & Notes
  • N. Fujita
    Ophthalmology,
    Wakayama Medical University, Wakayama, Japan
  • Y. Okada
    Ophthalmology,
    Wakayama Medical University, Wakayama, Japan
  • T. Uede
    Division of Molecular Immunology, Institute for Genetic Medicine, Hokkaido University, Sapporo, Japan
  • M. Matsuoka
    Ophthalmology, Kansai Medical University, Moriguchi, Japan
  • N. Ogata
    Ophthalmology, Kansai Medical University, Moriguchi, Japan
  • M. Miyajima
    Laboratory animal center,
    Wakayama Medical University, Wakayama, Japan
  • S. Saika
    Ophthalmology,
    Wakayama Medical University, Wakayama, Japan
  • Footnotes
    Commercial Relationships  N. Fujita, None; Y. Okada, None; T. Uede, None; M. Matsuoka, None; N. Ogata, None; M. Miyajima, None; S. Saika, None.
  • Footnotes
    Support  None.
Investigative Ophthalmology & Visual Science April 2010, Vol.51, 6186. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      N. Fujita, Y. Okada, T. Uede, M. Matsuoka, N. Ogata, M. Miyajima, S. Saika; Roles of Osteopontin in Development of Choroidal Neovascularization in Mice. Invest. Ophthalmol. Vis. Sci. 2010;51(13):6186.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To examine the roles of osteopontin (OPN) in experimental choroidal neovascularization (CNV). We reported that OPN play a significant role in the neovascularization of cultured endothelial cells and also is involved in development of corneal neovascularization in mice. (2008, 2009 ARVO)

Methods: : Laser photocoagulation was performed to produce a CNV model in mice. Effects of lacking OPN gene or systemic i. p. administration of anti-OPN antibody (400microg/mouse) were examined. We then further examined the effects of bone marrow (BM) transplantation between wild-type (WT) and OPN-null (KO) mice. The size of CNV was measured at 2 weeks by fluorescence angiograms.

Results: : Either OPN gene ablation or systemic administration of anti-OPN antibody attenuated development of experimental CNV in mice. There was no significant difference of the size of experimental CNV between KO mice that received WT BM and WT mice with KO BM.

Conclusions: : Loss of OPN gene or its function suppresses development of CNV in mice. Both OPN deficient tissue and BM-derived inflammatory cells have an important role of CNV. This favorable outcome could mean that OPN is a potential drug target for improving the outcome of CNV.

Keywords: choroid: neovascularization • cytokines/chemokines • inflammation 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×